Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000532576 | SCV000622627 | likely benign | Ataxia-telangiectasia syndrome | 2024-11-24 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000583702 | SCV000687655 | likely benign | Hereditary cancer-predisposing syndrome | 2017-09-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000583702 | SCV004849176 | uncertain significance | Hereditary cancer-predisposing syndrome | 2015-03-12 | criteria provided, single submitter | clinical testing | The c.5918+8A>C intronic alteration consists of a A to C substitution nucleotides after coding exon 38 in the ATM gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Myriad Genetics, |
RCV004592510 | SCV005084031 | likely benign | Familial cancer of breast | 2024-05-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004701600 | SCV005204047 | uncertain significance | not specified | 2024-06-22 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV004701600 | SCV005621833 | likely benign | not specified | 2024-01-23 | criteria provided, single submitter | clinical testing |